James G. Christensen
Independent DirectorDr. James G. Christensen, Ph.D., also known as Jamie, is CEO of Terremoto Biosciences, Inc. from August 2026. He is President and Head of Research & Development of Terremoto Biosciences, Inc. from January 2025. He is Director at Terremoto Biosciences, Inc. He serves as an Independent Director at BCTG Acquisition Corp since September 08, 2020. He has been Chief Scientific Officer of Mirati Therapeutics, Inc. since January 31, 2014 and served as its Executive Vice President since January 2019 until 2021. He is Executive Vice President of Mirati Therapeutics, Inc. He served as a Senior Vice President at Mirati Therapeutics, Inc. since January 2014. He served as Vice President of Research at Mirati Therapeutics, Inc. from June 2013 to January 2014. He served as the Senior Director of Oncology Precision Medicine in the Oncology Research Unit at Pfizer. He joined Pfizer in 2003 and his responsibilities there included leading nonclinical research efforts for oncology programs including sunitinib malate research activities and leading the nonclinical and translational biology efforts for other research and development programs including crizotinib. He participated as a Member of the Pfizer Cancer Research or Oncology Research Unit leadership team from 2005 to 2013. Prior to 2003, he was at SUGEN/Pharmacia as a Group Leader on the Preclinical Research and Exploratory Development team at SUGE, Inc. where he was responsible for leadership of Met and erbB family preclinical development programs and aspects of research and development for Sutent. He initiated his industry experience at Warner Lambert/Parke-Davis with research focus in RTK biology and RTK pathway biomarker development in the oncology therapeutic area. He has been Independent Director of Boundless Bio, Inc. since October 02, 2023. He has authored or co-authored over 100 peer-reviewed research articles in scientific journals including Science, Nature, Cancer Cell, New England Journal of Medicine and others. In addition, he participates on the editorial boards for Cancer Research and Molecular Cancer Therapeutics. He received his Ph.D. degree focusing in Molecular Pharmacology from North Carolina State University with dissertation research directed toward characterization of mechanisms of apoptosis dysregulation during the process of carcinogenesis. He holds B.S. in biology from Northern Illinois University. He received M.S. in Pharmacology and Toxicology at North Carolina State University.
公司职务
- 公司名称Boundless Bio, Inc.股票代码BOLD职务Independent Director共事同僚
- JOJessica OienPresident, Principal Executive Officer, Chief Legal Officer & Corporate Secretary
- JEJonathan E. LimCo-Founder & Independent Chairman
- DHDavid HinkleSenior VP of Finance, Controller & Corporate Treasurer
- MWMeredith WesleyChief Human Resources Officer
- JLJennifer LewIndependent Director
- PSPaul S. MischelChairman of Scientific Advisory Board
- BFBenjamin F. CravattScientific & Clinical Advisory Board Member
